Press Release: European Medicines Agency recommends first switch from prescription-only to non-prescription for a centrally authorised medicine

Author (Corporate)
Series Title
Series Details EMEA/CHMP/493770/2008 (23.10.08)
Publication Date 23/10/2008
Content Type

The medicine in question is Alli (orlistat) from Glaxo Group Limited, an anti-obesity medicine.
Source Link http://www.emea.europa.eu/humandocs/PDFs/EPAR/alli/4937708en.pdf
Subject Categories
Countries / Regions